“Beetlejuice,” an exuberantly ghoulish musical that was so on brand it came back from the dead, will end its Broadway run on Jan. 8, the show’s producers announced Tuesday.
This is the latest in a string of closings as Broadway grapples with diminished tourism, fewer Manhattan office workers and an inflation-driven rise in production costs following the lengthy pandemic shutdown of theaters. Last week, “The Phantom of the Opera,” which is Broadway’s longest-running show, announced that it would close in February; over the weekend “Dear Evan Hansen” closed and “Come From Away” is closing early next month.
“Beetlejuice,” adapted from the 1988 film, has had a bumpy ride on Broadway. It opened in 2019, but sales were weak enough that the Shubert Organization asked it to vacate the Winter Garden Theater; before it did so, sales rebounded thanks to a viral embrace of the show on social media, and then, while it was still trying to figure out its next steps, the pandemic shuttered all theaters.
The show, produced by Warner Bros. Theater Ventures and Langley Park Productions, returned to Broadway last April, now at the Marquis Theater, and its grosses have been decent — $930,798 during the week that ended Sept. 18 — but apparently not good enough to sustain a long run for a large-scale musical. At the time of its closing it will have played 679 performances, including the runs at both theaters.
The musical features songs by Eddie Perfect and a book by Scott Brown and Anthony King; it is directed by Alex Timbers. The show is planning a tour starting in December in San Francisco.
“Beetlejuice” was originally capitalized for $21 million, according to a filing with the Securities and Exchange Commission. It has not recouped those costs.